Anilides Concept

Vocabulary Service

MeSH

Overview

subject area of

1-phenyl-5-vinyl-2-imidazolidinethione, a proposed causative agent of Spanish toxic oil syndrome: Synthesis, and identification in one of a group of case-associated oil samples Journal Articles
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer Journal Articles
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer Journal Articles
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma Journal Articles
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial Journal Articles
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high‐risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621 Journal Articles
Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase Journal Articles
Androgen‐dependent regulation of medium and long chain fatty acids uptake in prostate cancer Journal Articles
Antibiotic stops ‘ping-pong’ match Journal Articles
Association of cabozantinib dose reductions for toxicity with clinical effectiveness in metastatic renal cell carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis Conferences
Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials Journal Articles
Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Journal Articles
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer Journal Articles
Discovery of antibiotics that selectively kill metabolically dormant bacteria Journal Articles
Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910 Journal Articles
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial Journal Articles
Guidelines for vismodegib in the management of periocular basal cell carcinoma Journal Articles
Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies Journal Articles
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review Journal Articles
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86) Journal Articles
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer Journal Articles
Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction. Journal Articles
Reversible Cabozantinib-Induced Cardiomyopathy Journal Articles
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer Journal Articles
Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab Journal Articles
Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide Journal Articles
The experiences of men receiving androgen deprivation treatment for prostate cancer: a qualitative study. Journal Articles
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer Journal Articles